The humoral immune responses of patients with periodontitis were evaluated to characterize the host response to Porphyromonas gingivalis. A sonic extract of P. gingivalis 381 from whole cells was fractionated by gel chromatography and ion-exchange chromatography. The fractionated extracts were evaluated by Western blot (immunoblot) analyses with patient sera. A dominant antigen was identified from the sonic extract with an apparent molecular mass of 53 kDa. The 53-kDa protein antigen (Ag53) was purified by affinity chromatography by using a monoclonal antibody. Ag53 was detected on the vesicle surface of P. gingivalis 381 by immunoelectron microscopy by using the monoclonal antibody and was detected as a major protein in the outer membrane and in vesicles by Western blot analysis. Monoclonal antibody cross-reactivity to Ag53 in the sonic extracts of P. gingivalis ATCC 33277, P. gingivalis 1021, and Porphyromonas endodontalis ATCC 35406 was revealed. Seventy-seven patients with periodontitis were examined for their responses to Ag53. Serum immunoglobulin G (IgG) from 54 patients reacted strongly to Ag53; however, serum IgG from the remaining 23 patients did not exhibit detectable reactivity at all to Ag53, even though the patients had high serum IgG titers to the sonic extract. Ag53 is a new marker that represents an interesting aspect of the humoral immune response to P. gingivalis in patients with periodontitis.
Porphyromonas gingivalis, a periodontopathic bacterium, has been isolated frequently from periodontal pockets (15, 20, 29-31, 35, 38) and exhibits numerous virulence factors (2, 4, 5, 7, 9, 11, 14, 28, 32, 34, 36) related to the destruction of periodontal tissues.
Many components of P. gingivalis are antigenic. The structural components, i.e., capsule (16, 17, 23) and fimbriae (25, 37) , and the materials that have biological activity, i.e., lipopolysaccharide (23, 25, 27) , hemagglutinin (23) , and trypsinlike protease (10) , have all been detected as antigenic determinants in sera from patients with periodontitis. Recently, several antigens from P. gingivalis have been purified (1, 19) . The isolated antigens vary in chemical composition and biological properties. However, the immunoglobulin G (IgG) antibody titers to all of the isolated antigens were reported to be elevated in sera of patients with periodontitis. These results make the relationship between P. gingivalis and the development, progression, and activity of periodontal disease difficult to interpret. The focus of these studies was the antibody titer in individual serum samples. Little attention was paid to intersubject variability. Because the host immune response in periodontitis is complex and the key factors that alter the course of periodontal disease have not been identified, it is appropriate to identify bacterial antigens that are important to host immune response and, potentially, to the progression of disease, in order to clarify the relationship between specific P. gingivalis antigens and serum antibody titer. Further In this study, we isolated an antigen from P. gingivalis 381 that showed strong antigenicity and clear differences in the humoral immune response among patients with periodontitis. We also characterized physical properties of the antigen.
MATERIALS AND METHODS
Bacteria and antigen preparation. P. gingivalis 381, 1021, and ATCC 33277, P. endodontalis ATCC 35406, Porphyromonas asaccharolyticus ATCC 27260, Prevotella intermedia ATCC 25611, Prevotella loescheii ATCC 15930, Prevotella corpolis ATCC 33547, and Prevotella denticola ATCC 33185 were grown and sonic extracts were prepared as described previously (21) . Except where noted, studies were done with P. gingivalis 381.
Outer membrane preparation. The outer-membrane-enriched fraction was prepared from P. gingivalis 381 as previously described (12) .
Antigen fractionation. The sonic extract (100 mg [dry weight]) was fractionated by using a Toyopearl HW-60F (Tosoh, Tokyo, Japan) column chromatograph (2.6 by 85 cm; equilibrated with 50 mM carbonate-bicarbonate buffer [pH 9.6]; flow rate, 0.5 ml/min) and a DEAE-Sepharose CL-6B (Pharmacia, Uppsala, Sweden) column chromatograph (1.6 by 10 cm; equilibrated with 10 mM Tris HCl buffer [pH 7.5]; flow rate, 0.7 ml/min). The binding antigens were eluted by use of a linear gradient of NaCl, as follows: 0 to 0.5 M (475 ml) and 0.5 to 2.0 M (100 ml). (20, 100) , and a-lactalbumin (14,400). The proteins in the gel were stained with Coomassie brilliant blue R-250.
Western blot. Western blot analyses were performed as described previously (12) . Sera from the patients with periodontitis and the healthy subjects were used at a final dilution of 1:100 with 5% (wt/vol) skim milk in Tris-buffered saline (10 mM Tris HCI buffer [pH 7.5], 0.9% NaCl) (M-TBS). Horseradish peroxidase-conjugated goat anti-human IgG antibodies (1:500 dilution with M-TBS; ICN Biochemicals, Costa Mesa, Calif.) or horseradish peroxidase-conjugated goat anti-mouse IgG antibodies (1:500 dilution with M-TBS; ICN) were used for detection.
Monoclonal antibodies. For immunization, a fraction (partially purified antigen) rich with 53-kDa protein antigen (AgS3) in DEAE-Sepharose CL-6B chromatography was further separated by SDS-PAGE. The acrylamide gel containing AgS3 was cut, hashed by passing through a 27-gauge hypodermic needle, and mixed with Freund complete adjuvant (Difco Laboratories, Detroit, Mich.). The prepared antigen (50 pil per mouse) was subcutaneously injected into BALB/c mice (male, 4 weeks old; Charles River Japan, Kanagawa, Japan). The animals were boosted intraperitoneally with 150 ±l1 of partially purified antigen (1 mg/ml) 3 weeks after primary immunization. Spleen cells andSP2/ 0-Agl4 BALB/c myeloma cells were fused under polyethylene glycol 4000 (E. Merck, Darmstadt, Germany) at 37°C. Hybrid cells were cultured selectively in HAT medium (Dulbecco's modified Eagle medium containing 2% hypoxanthine-aminopterin-thymidine solution [Flow Laboratories, McLean, Va.] and 10% fetal calf serum). Supernatant fluid from growing clones was screened for antibody production by Western blot by using a Screener Blotter (Sanplatech, Osaka, Japan). Positive clones were subjected to two limiting dilutions to assure monoclonality. The monoclonal antibody was obtained as ascites fluid from BALB/c mice injected with hybridoma cells and was purified with 50% saturated ammonium sulfate and DEAE-Sepharose CL-6B ion-exchange chromatography.
Purification of Ag53. A 20-mg (dry weight) amount of sonic extract was dissolved in 20 ml of binding buffer (10 mM Immunoelectron microscopy. Immunoelectron microscopy was performed as previously described (12) . P. gingivalis 381 cells were incubated with monoclonal antibody (1:50 dilution with phosphate-buffered saline) or BALB/c mouse serum, as the negative control, and were labeled with goat anti-mouse IgG conjugated to 10-nm-diameter colloidal gold spheres (Auro probe EM BAR G10; Janssen Lige Science Products, Olen, Belgium).
Isolation of vesicles. Vesicles of P. gingivalis 381 were isolated by the method described by Grenier and Mayrand (6) .
RESULTS
Antigen screening with patient sera. A dominant AgS3 (eluted at 0.15 M NaCl by DEAE-Sepharose CL-6B chromatography) in the sonic extract was detected in the sera of many patients and clearly showed differences in immunoreactivity among patients. The AgS3 reacted strongly to the serum IgG antibody from some patients with periodontitis ( Fig. 1, lanes 4 to 8 and 11 to 17) and reacted weakly or not at all to the serum IgG antibodies from the other patients with periodontitis (Fig. 1, lanes 1 to 3, 9, and 10) . Nevertheless, all of these patients showed extremely high serum IgG titers to the sonic extract from P. gingivalis 381. We were interested in the differences among the patients with periodontitis in their humoral immune response to the Ag53. The from the six cell lines formed a single immunoreactive blot at 53 kDa when Western blot analysis was used. MABgE, a monoclonal antibody produced from HCBgE, was used in further studies. The affinity chromatography profile with MABgE is shown in Fig. 2A . Purified antigen revealed a single band at 53 kDa when analyzed by SDS-PAGE (Fig.  2B, lane 2) .
Properties of Ag53. (i) Humoral immune response to Ag53. Serum IgG antibodies to purified Ag53 from the 77 patients with periodontitis and 10 healthy subjects were determined by Western blotting (Table 1) . Serum IgG from 54 of the patients with periodontitis reacted with Ag53; serum IgG from the remaining 23 patients and 5 of the healthy subjects did not react with Ag53 at all. Serum IgG from the other five healthy subjects reacted very weakly. More patients with early-onset periodontitis, RPP and JP, did not react to Ag53 than patients with AP (P = 0.08 between AP and JP; P = 0.09 between AP and early-onset periodontitis; by chisquare test). These results are shown in part in Fig. 3 .
(ii) Location of Ag53 in P. gingivalis 381. To clarify the localization of Ag53, P. gingivalis 381 treated with MABgEgold was observed by electron microscopy. Gold particles were detected bound to vesicles but were not detected elsewhere on P. gingivalis 381 cells (Fig. 4A) . The existence (Fig. 4C ).
(iii) Ag53 in other Porphyromonas and Prevotella species. Sonic extracts from P. gingivalis 1021, P. gingivalis ATCC 33277, P. endodontalis ATCC 35406, P. asaccharolyticus ATCC 27260, P. intermedia ATCC 25611, P. loesheii ATCC 15930, P. corporis ATCC 33547, and P. denticola ATCC 33185 were analyzed by Western blot by using monoclonal antibodies for detection. There was cross-reactivity only in the 67-kDa antigens from P. gingivalis ATCC 33277 and 1021 and in the 53-kDa antigen from P. endodontalis ATCC 35406. These immunoreactive blots were more weakly stained than the immunoreactive blot in P. gingivalis 381.
DISCUSSION
The Ag53 purified in this study is unique in that the patients with periodontitis and with elevated serum IgG antibody levels to crude antigen preparations from P. gingivalis 381 were clearly divided into two groups on the basis of their humoral immune responses to Ag53.
The patients in this study who had an elevated serum IgG antibody titer to the sonic extract from P. gingivalis 381 probably had been previously infected with P. gingivalis. However, it was not clear whether they had been infected by P. gingivalis with Ag53 or a common epitope. This obvious difference in response to Ag53 may simply reflect the difference in predominance of P. gingivalis with Ag53. Umemoto et al. (33) reported that the distribution of P. gingivalis serotype in patients with periodontitis was simple, that is, no patients harbored more than one serogroup of P. gingivalis.
The factors that play important roles in the process of antibody production are genetically controlled. Thus, the capacity for antibody production varies with the subject. Therefore, it is possible that some patients with periodontitis simply will not react to Ag53, even if the homologous isolate expresses the antigen. A mother and daughter previously reported with a history of early-onset periodontitis (24) were subjects of this study as well. Their serum IgG antibody titers against P. gingivalis 381 were high, as follows: the mother, with RPP, had a titer of 3,939 ELISA units, and the daughter, with JP, had a titer of 4,956 ELISA units. However, neither responded to Ag53 (Fig. 3, 
